Literature DB >> 2206564

Radium treatment for hemangioma in early childhood. Reconstruction and dosimetry of treatments, 1920-1959.

M Lundell1, C J Fürst, B Hedlund, L E Holm.   

Abstract

Between 1920 and 1959, a total of 14,647 children younger than 18 months were treated at Radiumhemmet with ionizing radiation for skin hemangioma. Seventy-two percent of the children were treated with radium needles or tubes, which were put into glass capsules and then applied to the hemangioma. The absorbed doses to different organs have been measured in a tissue equivalent phantom, representing a 6-month-old child. For a standard treatment of 8 Gy to the hemangioma the mean absorbed doses to the brain, eye lens, parotid gland, thyroid, breast anlage and gonads from 28 different treatment areas were 0.03-0.2 Gy. The mean absorbed dose to the organs in younger (less than 2 months) and older (14-18 months) children were up to 50% higher (0.04-0.1 Gy) and 33% lower (0.02-0.06 Gy) respectively, than for a 6-month-old child. The uncertainty in organ absorbed doses for each patient depended mostly on the estimation of the distance between the applicator and the site.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206564     DOI: 10.3109/02841869009090049

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  3 in total

1.  Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study.

Authors:  Per Hall; Hans-Olov Adami; Dimitrios Trichopoulos; Nancy L Pedersen; Pagona Lagiou; Anders Ekbom; Martin Ingvar; Marie Lundell; Fredrik Granath
Journal:  BMJ       Date:  2004-01-03

2.  Sarcomatoid Tumor following Radium Treatment.

Authors:  Wahida Chakari; Anette Pedersen Pilt; Jørgen Lock-Andersen
Journal:  Case Rep Dermatol       Date:  2018-01-31

3.  No clinically relevant effect on cognitive outcomes after low-dose radiation to the infant brain: a population-based cohort study in Sweden.

Authors:  Malin Blomstrand; Erik Holmberg; Maria A I Aberg; Marie Lundell; Thomas Björk-Eriksson; Per Karlsson; Klas Blomgren
Journal:  Acta Oncol       Date:  2014-04-03       Impact factor: 4.089

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.